Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Dexmedetomidine for Pediatric Sedation in Non-invasive Radiological Procedures
2025-522778-34-00Phase 2Authorised
- Sponsor
- Antwerp University Hospital
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dexmedetomidine in None, sponsored by Antwerp University Hospital. Primary endpoint: Success rate after one dose of intranasal dexmedetomidine. Planned start Nov 2025; status: authorised.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on 2025-522778-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-522778-34-00.